Comorbidities Factors and Hypertension in Relation to Covid-19

Abstract

Objective: Hypertension is commonly accompanied by many comorbidities that are major determinant factors for the severity of COVID-19. To investigate Comorbidities factors and hypertension in relation to COVID-19 Design and method: A retrospective analysis that independent factors in hospitalized patients with COVID 19. Results: A study consisting of 164 COVID 19 patients with hypertension and comorbidities factors (HTCOB) was higher severity and complications in the 49 cases than in the 115 cases with only hypertension cases. Chest computed tomographic scans showed bilateral patchy shadows or ground glass opacity in the lungs of 14 COB patients. The median time from first symptom to dyspnea was 5 days, to hospital admission was 21 days in the HTCOB. Multivariable-adjusted analysis revealed that male sex, age over 60 years old, obesity and hypertension were independent factors for COVID 19 severity. Adjustment for age, high lactate dehydrogenase (LDH), and D dimer, hypertension with obesity was independently associated with the severity of COVID 19 on admission Conclusions: There patients with both obesity and hypertension are at particularly high risk for severe disease in COVID-19 and thus require careful observation and intensive treatment.